E-LIB Suche - Ergebnisse für: Boisteau, Emeric

1

Clinico-biological factors predicting the benefit of the LV..:

Boisteau, Emeric ; Dahan, Laetitia ; Williet, Nicolas...
The Oncologist. , 2024

Link: https://doi.org/10.1093/..

2

AGR2 protein expression in colorectal tumour epithelialcomp..:

Chevet, Eric ; Bassal, F ; Beq, Stéphanie...
Gut. 72 (2022) 12 - p. 2385-2386 , 2022

Link: https://doi.org/10.1136/..

3

SOCRATE-PRODIGE 55 trial: A randomized phase II study to ev..:

Boisteau, Emeric ; François, Eric ; Aparicio, Thomas...
Digestive and Liver Disease. 54 (2022) 6 - p. 747-754 , 2022

Link: https://doi.org/10.1016/..

4

MiR-31-3p do not predict anti-EGFR efficacy in first-line t..:

Boisteau, Emeric ; Lespagnol, Alexandra ; De Tayrac, Marie...
Clinics and Research in Hepatology and Gastroenterology. 46 (2022) 5 - p. 101888 , 2022

Link: https://doi.org/10.1016/..

5

Anterior gradient proteins in gastrointestinal cancers: fro..:

Boisteau, Emeric ; Posseme, Céline ; Di Modugno, Federico...
Oncogene. 41 (2022) 42 - p. 4673-4685 , 2022

Link: https://doi.org/10.1038/..

6

When helping the minority of patients may hurt the majority..:

Tron, C ; Lemaitre, F ; Boisteau, Emeric..
Digestive and Liver Disease. 53 (2021) 2 - p. 258-260 , 2021

Link: https://doi.org/10.1016/..

7

Maintenance therapies in metastatic pancreatic cancer: pres..:

Hammel, Pascal ; Vitellius, Carole ; Boisteau, Émeric...
Therapeutic Advances in Medical Oncology. 12 (2020) - p. 175883592093794 , 2020

Link: https://doi.org/10.1177/..

8

Improving the screening of precancerous anal lesions in hig..:

Moreau, Johanna ; Siproudhis, Laurent ; Brochard, Charlène...
Digestive and Liver Disease. 52 (2020) 11 - p. 1359-1364 , 2020

Link: https://doi.org/10.1016/..

9

AGR2 protein expression in colorectal tumour epithelialcomp..:

Chevet, Eric ; Bassal, F ; Beq, Stéphanie...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10715535/. , 2023

Link: http://www.ncbi.nlm.nih...

10

Anterior gradient proteins in gastrointestinal cancers: fro..:

Boisteau, Emeric ; Posseme, Céline ; Di Modugno, Federico...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41388-022-02452-1. , 2022

Link: https://hal.science/hal-..

11

MiR-31-3p do not predict anti-EGFR efficacy in first-line t..:

Boisteau, Emeric ; Lespagnol, Alexandra ; de Tayrac, Marie...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.clinre.2022.101888. , 2022

Link: https://hal.science/hal-..

12

MiR-31-3p do not predict anti-EGFR efficacy in first-line t..:

Boisteau, Emeric ; Lespagnol, Alexandra ; de Tayrac, Marie...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.clinre.2022.101888. , 2022

Link: https://hal.science/hal-..

13

MiR-31-3p do not predict anti-EGFR efficacy in first-line t..:

Boisteau, Emeric ; Lespagnol, Alexandra ; de Tayrac, Marie...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.clinre.2022.101888. , 2022

Link: https://hal.science/hal-..

14

AGR2 protein expression in colorectal tumour epithelialcomp..:

Chevet, Eric ; Bassal, F ; Beq, Stéphanie...
info:eu-repo/semantics/altIdentifier/doi/10.1136/gutjnl-2022-328739. , 2022

Link: https://univ-rennes.hal...

15

AGR2 protein expression in colorectal tumour epithelialcomp..:

Chevet, Eric ; Bassal, F ; Beq, Stéphanie...
info:eu-repo/semantics/altIdentifier/doi/10.1136/gutjnl-2022-328739. , 2022

Link: https://univ-rennes.hal...